Ads
related to: paid clinical trials- What Is KEYTRUDA?
Learn About What KEYTRUDA Is & How
It May Help Eligible Patients.
- Paying for KEYTRUDA
Find Assistance and Payment
Information for Eligible Patients.
- What Is KEYTRUDA?
Search results
Kyverna Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
WRBL Columbus· 2 hours agoKyverna Therapeutics, Inc. (Nasdaq: KYTX), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune ...
Vaccine trial patient files first US lawsuit against AstraZeneca
The Telegraph via Yahoo News· 1 day agoAn American woman who took part in the US clinical trial of the AstraZeneca Covid vaccine is suing...
Utah mom sues AstraZeneca, claiming she was left ‘permanently disabled’ in COVID vaccine trial
New York Post· 10 hours ago“I walked into the... claims she had signed a consent form with the manufacturer at the beginning of...
FDA extends review of Ascendis Pharma's hypoparathyroidism drug By Investing.com
Investing.com· 3 hours agoAscendis Pharma A/S (NASDAQ:ASND), a biopharmaceutical company, has received notice from the U.S....
Earnings call: MiNK Therapeutics advances in cancer therapy programs By Investing.com
Investing.com· 4 hours agoThe company's CAR iNKT Cell Therapy, MiNK-215, targeting solid tumors, has received significant...
Earnings call: INOVIO outlines 2024 plans, reports Q1 financials By Investing.com
Investing.com· 13 hours agoINOVIO Pharmaceuticals Inc. (NASDAQ: INO), a biotechnology company, has reported its financial...
ProKidney on track to resume manufacturing in a few months, discloses exec compensation - Triad...
The Business Journals· 3 hours agoIn announcing its financial results for the first quarter of 2024 on Monday, ProKidney (NASDAQ:...
Cost and Viltepso: Financial assistance options, savings, more
Medical News Today· 21 hours agoIt’s important to note that Viltepso received approval from the Food and Drug Administration (FDA)...
Local VC firm gets top ranking for investor returns
The Business Journals· 1 day agoDan Conner describes the strategy of launching St. Louis-based Ascend Venture Capital as akin to a pharmaceutical company startingclinical trials. Like ...
Earnings call: Anavex Life Sciences eyes Alzheimer's, Rett syndrome trials
Investing.com· 6 days agoAnavex Life Sciences Corp. (NASDAQ: AVXL ) held its fiscal 2024 second-quarter earnings call,...
